TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Cannabis Stocks
A $10,000 Investment in Weed Stocks at the Beginning of 2019 Is Worth This Much Today

Stocks for Beginners
These 2 “What ifs” Could Kill Your Cannabis Stocks

Tech Stocks
3 Oversold Stocks That Could Be Great Buys Right Now

Cannabis Stocks
Pricey Weed Stocks: A Lesson From Cheap Oil

Cannabis Stocks
Which Marijuana Stock Is the Best to Hold in This Bearish Spell?

Cannabis Stocks
Canopy Growth (TSX:WEED) Dumped its Visionary: Investors Should Do the Same to the Stock!

Cannabis Stocks
Canopy Growth (TSX:WEED): Beware the Disruptive Cronos Group (TSX:CRON)

Cannabis Stocks
Should You Buy Canopy Growth (TSX:WEED) on Weakness?

Cannabis Stocks
Which Canadian Cannabis Names Will Benefit Most From U.S. Legalization?

Cannabis Stocks
Is Aurora Cannabis (TSX:ACB) a Steal at Under $10?

Cannabis Stocks
Forget Canopy Growth (TSX:WEED): This Weed Upstart Has Insanely High Growth Potential
